Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300299
- Awardee
-
Lonza Walkersville, Inc. UEI LEEXJC9L4NF5
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,264
Award facts
- Contract value 50% obligated
-
- $3,263.52 Current, with exercised options
- $6,527.04 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
Lonza Walkersville, Inc. received a $6,527.04 firm fixed price contract award from the National Institutes of Health (NIH) Office of the Director on November 8, 2012, for the procurement of drugs and biologicals. This contract call was placed against Lonza Walkersville's existing $10 million Blanket Purchase Agreement with the HHS Office of Logistics and Acquisition Operations, valid through December 31, 2025. The award involved no set-aside designation, indicating open competition. The work is to be performed in Bethesda, Maryland, with an ultimate completion date of December 31, 2012.
Lonza Walkersville, a foreign-owned manufacturer specializing in biological materials and laboratory equipment, has established itself as a critical supplier to federal biomedical research institutions. The company's expertise encompasses cell culture media, specialized cell lines, transfection devices, and scientific instrumentation that support research across multiple NIH institutes and centers. This particular task order represents a routine procurement under the existing BPA framework, which streamlines acquisition of biological materials and research supplies essential to advancing the NIH's research mission in areas including cancer studies, infectious diseases, and cellular engineering.
Quick answers
Who was awarded contract HHSN26300299?
HHSN26300299 was awarded to Lonza Walkersville, Inc. by Office of the Director (National Institutes of Health) on November 8, 2012.
How much is contract HHSN26300299 worth?
The government has obligated $3,264 on HHSN26300299. Its potential value, with all options, is $6,527.
Is contract HHSN26300299 an order under another contract?
Yes. HHSN26300299 is a BPA call under HHSN263199900049886B, a blanket purchase agreement.
Was contract HHSN26300299 competed?
The extent of competition for HHSN26300299 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award